A coarctation hypertensive rat model was used to examine the effects of elevated blood pressure on basement membrane component synthesis by cardiac myocytes and aorta using immunohistochemistry and Northern blot analysis. Carotid arterial pressure increased immediately on coarctation, and left ventricular hypertrophy was maximal within S days. In immunohistochemical studies, fibronectin and laminin were increased and the basement membrane chondroitin sulfate proteoglycan decreased in both the subendothelial space and smooth muscle cell basement membranes of the aorta above the clip compared with controls, whereas only fibronectin was elevated in the aorta below the clip. No change in basement membrane staining intensity for the cardiac myocytes was observed. Alterations in steady-state mRNA levels for fibronectin and laminin in the aorta paralleled those observed by immunohistochemical analysis with regard to protein and tissue type affected as well as intensity of the changes. However, changes in mRNA levels (but not protein deposition) for perlecan and type IV collagen were also observed in aortas from hypertensive rats compared with controls. Increases in steady-state mRNA levels for all basement membrane components in the heart and vasculature peaked before maximal cardiac hypertrophy (5 days). These studies indicate that alterations in basement membrane component deposition in the hypertrophied vasculature occur at both transcriptional and translational levels and suggest that the cell attachment glycoproteins fibronectin and laminin may be important factors in the vascular response to elevated transmural pressure. organized meshworks of proteins, glycoproteins, and proteoglycans in close association with the cellular components of tissues. The proteins that comprise the BM, including type IV collagen, fibronectin, laminin, entactin, perlecan (the BM heparan sulfate proteoglycan), and the BM chondroitin sulfate proteoglycan (BM-CSPG), 1 perform diverse functions. The principal component of all BMs is the nonfiber-forming collagen, type IV collagen, molecules of which are thought to associate to form a meshwork to which many other components, such as fibronectin, laminin, and perlecan, can attach to produce the mature BM structure. In addition, many BM components, particularly fibronectin, laminin, type IV collagen, and entactin, play an essential structural role by anchoring cells to the interstitial matrix.
B asement membranes (BMs) are complex, highly organized meshworks of proteins, glycoproteins, and proteoglycans in close association with the cellular components of tissues. The proteins that comprise the BM, including type IV collagen, fibronectin, laminin, entactin, perlecan (the BM heparan sulfate proteoglycan), and the BM chondroitin sulfate proteoglycan (BM-CSPG), 1 perform diverse functions. The principal component of all BMs is the nonfiber-forming collagen, type IV collagen, molecules of which are thought to associate to form a meshwork to which many other components, such as fibronectin, laminin, and perlecan, can attach to produce the mature BM structure. In addition, many BM components, particularly fibronectin, laminin, type IV collagen, and entactin, play an essential structural role by anchoring cells to the interstitial matrix. 12 Because of its high net negative charge density, the BM heparan sulfate proteoglycan perlecan allows the BM to act as a selectively permeable barrier. 13 - 5 Perlecan has also been demonstrated to bind and sequester growth factors. 68 The cell attachment glycoproteins fibronectin and laminin are be-' 10 Alterations in the amounts, distribution, and associations of components that comprise the BMs have been demonstrated to dramatically affect cell, tissue, and organ function. 13 - 4 The regulation of extracellular matrix (ECM) synthesis by the heart and blood vessels is of particular interest, because the heart and blood vessels undergo cyclic alterations in transmural pressure, stretch, and shear force. One of the most important functions of the ECM produced by cardiac and vascular tissue is to moderate the intensity of these physical forces in both normal and pathological conditions. 1121 Recently, investigators have begun to examine alterations in BM component synthesis in vascular endothelial and smooth muscle cells and cardiac tissue in response to hypertension. 2226 However, a comprehensive examination of the effects of hypertension on the alterations in the synthesis/deposition of many BM components by vascular and cardiac tissues has not been performed. In the present study, we used a rat coarctation model to examine the effects of systemic hypertension on the synthesis of several BM components in the heart and aorta with Northern blot analysis and immunohistochemical techniques.
Birmingham, and James B. McCarthy, University of Minnesota, Minneapolis, respectively) derived from the Englebreth, Holm, Swarm tumor were used to prepare polyclonal antibodies in female New Zealand White rabbits using the RIBI adjuvant system (RIBI Immunochemicals, Hamilton, Mont) or Freund's adjuvant. Sera taken from individual rabbits before and after inoculation were tested for reactivity against the antigen of interest as well as cross-reactivity against other BM components using enzyme-linked immunosorbent assays (ELISA), Western blotting techniques, or both. Antisera directed against laminin and type IV collagen were also tested for specific staining of BM structures in cryostat sections of several rat tissues. Other polyclonal antibodies against BM components used in this study, such as anti-rat plasma fibronectin, 27 anti-perlecan, 28 and a monoclonal antibody (2D6) directed against the BM-CSPG, 29 were characterized previously.
Coarctation Model
Hypertension was produced in male Sprague-Dawley rats (approximately 190 g body weight) using the method of Liu et al. 30 Briefly, rats were anesthetized with ether, and a section of the abdominal aorta immediately caudal to the diaphragm was cleared of connective tissue. A silver clip (coarctation hypertensive, 0.81 mm internal diameter; sham, 1.70 mm internal diameter) was placed around the aorta above the bifurcation of the right renal artery. The incision was closed, and penicillin G (50 fiL, 250 mg/mL in 0.9% saline) was administered intramuscularly. Rats were maintained individually in plastic cages and given rat chow (Ralston Purina 5001) and tap water ad libitum.
Preliminary studies were performed to examine temporal changes in carotid and femoral arterial pressures and right and left ventricular plus septal masses from 0 to 30 days after coarctation. Two animals were used for each time point. For immunohistochemical analysis of type IV collagen, fibronectin, laminin, perlecan, and the BM-CSPG, a second set of four, 14-day coarctation hypertensive rats and four shams was used. A third set of six hypertensive and six sham rats was prepared for analysis of alterations in steady-state levels of BM component mRNA (Northern analysis) including fibronectin, laminin-B 2 , perlecan, and a^type IV collagen at 1, 3, 10, and 20 days after surgery.
The efficacy of the coarctation procedure was examined by measuring blood pressure in the carotid artery and lower abdominal aorta of randomly selected hypertensive and sham rats by direct cannulation of these vessels after ether anesthesia on the day preceding tissue collection. Normalized right and left ventricular plus septal weights (corrected for body weight) were determined after tissues had been taken and were used as another measure of the adequacy of the coarctation procedure. National Institutes of Health guidelines for the care and use of animals were observed throughout all phases of experimentation and handling. Animal care and experimental protocols were also approved by the Institutional Animal Care and Use Committees of the University of Alabama at Birmingham and the University of Kentucky.
Immunohistochemistry
For immunohistochemistry, 14-day coarctation hypertensive and sham rats were anesthetized with pentobarbital (Nembutal, 50 mg/kg). To clear the vasculature of blood, an 18-gauge needle connected to a perfusion pump was inserted into the left ventricle (LV), and filtered (0.2 urn) phosphate-buffered saline (g/L: Nad, 8.0; KC1, 0.2; KH 2 PO 4 , 0.2; NaHjPCv, 1.1; pH 7.4, room temperature) was perfused through the vasculature at pressures corresponding to the carotid arterial pressures of the animals. The vasculature was then perfused with a filtered fixative solution (acid alcohol; 96:3:1, ethanol/glacial acetic acid/ water, approximately 3 minutes). Tissues were removed and placed in acid alcohol for at least another 24 hours before embedding. Tissues were processed and embedded in paraffin using standard techniques. Immunohistochemical analysis was performed on hyaluronidase-treated sections (50 000 U/mL) 31 according to the methods of McCarthy et al. 29 The aorta anterior to (AOR t ) and posterior to (AOR I) the coarctation site and the right ventricle (RV) and LV were used for immunofluorescence studies. Sections of aorta were taken at constant distances either 1.0 cm posterior to the top of the aortic arch or 0.5 cm posterior to the coarctation site.
Antisera to fibronectin, laminin, and type IV collagen were diluted 1:50; antisera to perlecan were used at a dilution of 1:30; and for the monoclonal antibody against the BM-CSPG, undiluted ascites fluid was used. Secondary antibodies [rhodamine-labeled goat antirabbit IgG F(ab) 2 (Jackson ImmunoResearch Laboratories Inc, West Grove, Pa) or fluoroscein isothiocynanate-labeled goat anti-mouse IgG (Cappel)] were applied using a dilution of 1:100 (antibody/phosphatebuffered saline) to visualize the primary antibodies. Control staining with preimmune sera or secondary antibodies only was routinely performed to verify the specificity of the primary antibodies.
Sections were examined with a Nikon Optiphot microscope equipped with appropriate epifluorescence filters. Photomicrographs of control and experimental tissues were taken using the same exposure times for each pair of slides (four pairs in all for each tissue) so that direct comparisons of staining intensities could be made. Care was taken to maintain the same exposure and development times during all subsequent photographic work. For the immunohistochemical studies, only those changes observed in at least three of four comparisons between the coarctation hypertensive and sham rats are discussed below, except where noted.
Northern Analysis
For Northern blot analysis, tissues (AOR t , AOR | , RV, and LV) were removed from freshly killed (ether overdose) sham and coarctation hypertensive rats. After loose connective tissue was removed, tissues were snapfrozen by immersion in liquid nitrogen and maintained at -80°C until use. AOR f and AOR | of six control and coarctation hypertensive rats were taken 3, 10, and 20 days after placement of the clip; RV and LV tissues were taken 1,10, and 20 days after surgery. Isolation of total RNA and Northern analysis were performed according to the methods of Claycomb and Lanson. within a group, three RVs, or portions (approximately 200 mg) from three LVs were used for Northern analyses. Because RNA was extracted from control and coarctation hypertensive rats over a span of 20 days, during which the rats were growing, comparisons of mRNA isolated from control or hypertensive tissues at different times are not valid. Thus, in interpreting the data, only comparisons of steady-state levels of mRNA between control and coarctation hypertensive rats within a given day were used. The cDNA probe for rat fibronectin is from a region encoding the 10th and 11th type I repeat (a gift from Dr R. Hynes) and recognizes the 7.9-kb band corresponding to fibronectin on Northern blot analysis. The cDNA probes for laminin-B 2 , perlecan, and a r type IV collagen were produced from a library of Englebreth, Holm, Swarm tumor RNA and were received from Sasaki and Yamada, 33 Noonan et al, 34 and Nath et al, 35 respectively. These probes specifically hybridize to 8.0 kb (lamininBj), 6.7 kb (type IV collagen), and 12 kb (perlecan) bands on Northern analysis. cDNA probes for the BM-CSPG are currently unavailable.
Statistics
All statistical analyses were performed using Student's t test for paired or unpaired data. The level of statistical significance was at a value
Results

Antibody Characterization
Antibodies prepared against laminin and type IV collagen did not cross-react with other purified BM components as determined by ELISA (data not shown).
Western blot analysis and ELISA demonstrated that antibodies to laminin recognized subunits corresponding to the A and B chains of laminin, whereas antisera directed against type IV collagen recognized purified type IV collagen. Both laminin and type IV collagen antisera specifically recognized profiles of BMs in cryostat sections from several rat tissues.
Time Course of Coarctation Hypertension
Coarctation hypertension had no apparent effect on weight gain compared with the sham hypertensive group (Fig 1A) . Carotid arterial pressure increased immediately after placement of the constricting clip (Fig IB) , and although the pressure differential between the carotid artery and AOR [ in coarcted animals varied considerably throughout the course of the study, it was always higher than in sham coarcted animals. RV weights (normalized to body weight) from the hypertensive and sham groups did not appear to be different ( Fig  1C) ; however, normalized LV mass was twice control values in coarcted rats by 5 days after placement of the clip ( Fig ID) . This difference in LV mass between the two groups remained constant over the next 25 days ( Fig  ID) . Similar results were observed in comparisons of body weights, carotid and AOR 1 pressures, and RV and LV weights for the 14-day coarctation hypertensive and sham rats used for the immunohistochemical studies (Table 1) .
Immunohistochemistry, Aorta
A marked and consistent increase in staining for fibronectin (Fig 2a and 2b) and laminin (Fig 2c and 2d) was observed in sections of AOR t from coarcted rats when compared with sections from the corresponding area of the aorta of sham coarcted rats. The subendothelial BM of aortas from coarctation hypertensive rats also stained much more intensely for both fibronectin (Fig 2a) and laminin (Fig 2c) than the same area from sham aortas (Fig 2b and 2d) . The subendothelial BMs of AOR f from hypertensive rats were negative for the BM-CSPG, even though the presence of a subendothelial BM was verified (compare Fig 2e with Fig 2a, which are from the same aorta). The media of the hypertrophied AOR t was more sparsely stained for the BM-CSPG than corresponding areas from sham AOR f as well (Fig 2e and 2f) . The subendothelial BM of sham AOR t exhibited intense staining for BM-CSPG, and homogeneous staining for BM-CSPG was observed throughout the aortic media from this group (Fig 2f) . The degree of staining for perlecan was similar in both hypertensive (Fig 2g) and control (Fig 2h) aortas, as was staining for type IV collagen (not shown).
In two of four coarctation hypertensive rats, fibronectin staining in AOR | was more intense than in the corresponding sham tissues (Fig 3) . Other BM components (laminin, type IV collagen, perlecan, and BM-CSPG) in the AOR | did not differ between sham and coarctation hypertensive animals (data not shown).
Immunohistochemistry, Myocardium
LV myocardial capillaries stained positively for laminin and type IV collagen (Fig 4a through 4d) as well as for fibronectin and the BM-CSPG (not shown), and there appeared to be no difference in the staining intensities between sham and hypertensive tissues. Myocytic BMs from the LV also exhibited prominent staining for laminin and type IV collagen (Fig 4a through  4d ), but these structures stained only minimally for fibronectin and the BM-CSPG. There did not appear to be differences in staining intensities between control and hypertensive tissues despite overt hypertrophy of the LV myocytes in the latter group. Similar staining patterns were observed for fibronectin, laminin, type IV collagen, and BM-CSPG in the nonhypertrophied RV, where again there was no difference between hypertensive and sham coarcted tissues (not shown). All cardiac myocytes were negative for the BM-associated heparan sulfate proteoglycan, perlecan, as reported previously.
28 Table 2 summarizes the immunohistochemical alterations in BM components in vascular and cardiac tissues of coarcted compared with sham rats. Fig 5 shows the time course for alterations in steadystate mRNA levels for fibronectin, laminin-Bj, perlecan, and aptype IV collagen in aortic tissues from coarctation hypertensive and control rats by Northern analysis. For this study, comparisons were made only between sham and hypertensive rats within a given day and not over time. In the AOR t of hypertensive rats, fibronectin and the B2 chain of laminin were elevated by day 3 and remained elevated through day 10 of coarctation compared with the AOR T from day 10 shams. Temporal changes in steady-state levels of the core protein of perlecan and aptype IV collagen were similar to fibronectin and laminin, although the magnitude of the differences between sham and hypertensive tissues was smaller. At day 20 after coarctation, steady-state mRNA levels for all BM components examined were higher in sham aortas than in aortas from coarcted rats (Fig 5) . In general, steady-state levels of BM component mRNAs in AOR j were increased in coarctation hypertensive rats compared with shams. The magnitude of the differences between sham and hypertensive tissues was smaller in the AOR I from hypertensive rats compared with time-matched shams than seen in the AOR t , however. In addition, maximal increases in steady-state levels of mRNA for the BM components in the AOR i occurred at a later time (10 days) after coarctation compared with those in the AOR t • Fibronectin-specific mRNA was virtually undetectable in LVs of both hypertensive and control rats throughout the study (Fig 6) . In contrast, steady-state mRNA levels for both laminin and type IV collagen were detectable in mRNA from LVs of sham and coarctation hypertensive rats. Steady-state levels of mRNA for laminin and type IV collagen were significantly reduced in LVs taken from coarctation hypertensive rats compared with shams at 10 days of hyperten-sion (Fig 6) . By 20 days of coarctation, substantial increases in steady-state levels of mRNA for laminin and type IV collagen were observed in the LVs of hypertensive versus time-matched sham rats (Fig 6) . Steady-state levels of mRNA for BM components were much greater in RVs than in LVs of both control and hypertensive rats (Fig 6) . Slight increases in the transcripts for fibronectin, laminin, and perlecan were observed in RVs of hypertensive rats compared with shams by 10 days after coarctation; the direction of this differential expression was reversed by day 20 (Fig 6) .
Northern Analyses
Discussion
To our knowledge these data represent the most comprehensive examination of alterations in the expression and deposition of BM components produced by cells of aortic and ventricular tissues in response to pressure-overload-induced hypertension. The molecules examined typify the proteins, glycoproteins, and proteoglycans present in the BM and represent proteins with distinct and important functions within the heart and blood vessels. Examinations of cardiac and aortic tissues in both pressure-overloaded (LV, AOR f ) and normotensive (RV, AOR j ) regions revealed that although directly applied pressure/stretch is an important stimulus for alterations in BM component deposition, it is apparent that other possibly neural/humoral factors induced by hypertension influence BM component synthesis in areas of the cardiovascular system not directly exposed to increased pressure. Although speculative, the marked increases in the cell attachment glycoproteins fibronectin and laminin in the AOR f suggest that enhanced attachment of smooth muscle and endothelial cells to the surrounding matrix is an important response to hypertension, and this may have relevant pathophysiological consequences. The decrease in immunolocalizable BM-CSPG suggests a regression of the mature vascular BMs to a more undifferentiated state.
Changes in Vascular Basement Membranes, Immunohistochemistry
The results of the immunohistochemical analyses are in general agreement with previous findings of alterations in ECM component amount, type, or both in the cardiovascular system in several models of hypertension. Although most previous studies have focused on changes in interstitial ECM components, studies that have examined BMs in hypertensive blood vessels and cardiac tissue corroborate the results presented here. Guyton et al 22 observed that increased subendothelial BM width in aortas from coarctation hypertensive rats was primarily due to increased deposition of BM-like material. McGuire et al 23 observed increases in fibronectin and laminin in the subendothelial space of conducting vessels from spontaneously hypertensive rats (SHR) using both immunohistochemistry and Northern blot analysis. However, unlike the present study, several other BM components, including type IV collagen and perlecan, were also found by immunohistochemistry to be increased in large vessels from SHR compared with normotensive Wistar-Kyoto rats. 23 Similarly, we have previously described differences in proteoglycan synthesis between SHR and coarctation hypertensive rats. 47 The dissimilarity between our results and those of other investigators 43 suggests that there are fundamental differences in the factors influencing the production of some ECM components between genetic models of hypertension, such as the SHR, and models in which hypertension is induced by surgical (coarctation of the aorta) intervention.
Immunohistochemical alterations observed in BM components were generally confined to the pressure-overloaded portion of the aorta, indicating that physical forces, such as pressure, stretch, or both, are primary stimuli for changes in the production and distribution of laminin, BM-CSPG, and fibronectin in coarctation hypertension. Fibronectin was also observed in the AOR | . In vitro, physical forces, such as pressure, stretch, and shear force, have been demonstrated to stimulate ECM synthesis in vascular endothelial and smooth muscle cells 44 -48 "; however, the mechanisms through which these physical forces operate have yet to be determined.
Increases in fibronectin were observed in the AOR | of two of four coarctation hypertensive animals, suggesting that the production of fibronectin may be under the influence of additional factors expressed during hypertension. This is consistent with our previous demonstration of elevated proteoglycan production in the normotensive, nonhypertrophied RV and kidneys of coarctation hypertensive rats. 47 We have observed increases in the expression of steady-state levels of mRNA for the potent ECM synthesis stimulating factor, transforming growth factor-^1, in the aorta both above and below the coarctation site of 3-day coarctation hypertensive rats compared with shams (unpublished observations). Thus, the observed increases in BM component synthesis in the aorta below the coarctation site may be mediated by alterations in the synthesis of this growth factor.
Whereas the distributions of type IV collagen, laminin, perlecan, and the BM-CSPG are limited to BMs, fibronectin is also found in both plasma and the interstitium. Thus, by immunofluorescence microscopy, the exact structural location of the fibronectin within the heart and aorta cannot be determined. However, the fact that laminin, a BM cell attachment glycoprotein with functions similar to fibronectin, is increased in the subendothelial space and media of aortas from coarctation hypertensive rats suggests that at least some of the increased fibronectin deposited in the aorta is localized to the BMs. It is also possible that the source of the fibronectin may actually be the plasma; however, the increase in the steady-state level of mRNA for fibronectin in the coarctation hypertensive aorta indicates that the synthetic capacity of this vessel for fibronectin is increased by coarctation as well.
Changes in Vascular Basement Membranes, Northern Analysis
The largest increases in steady-state levels of BM component-specific mRNA in coarctation hypertensive rats compared with time-matched shams were observed for fibronectin and laminin in the AOR t • These increases occurred before maximal cardiac hypertrophy, suggesting that alterations in BM components are a constituent of aortic hypertrophy and the adaptation of conducting vessels to increased pressure. Increases in the steady-state levels of fibronectin mRNA in the AOR i are also consistent with the immunohistochem-ical results. Similar increases in steady-state levels of mRNA for fibronectin and deposition of fibronectin have been observed in the aorta in other models of systemic hypertension, including deoxycorticosteronesalt, chronic infusion with angiotensin II, and the SHR. 23, 24 The Northern analysis and immunohistochemistry are apparently contradictory with regard to observed inby guest on July 8, 2017 http://hyper.ahajournals.org/ Downloaded from FIG 2. (Facing page) . Photomicrographs show immunohistochemical localization of fibronectin (a and b), laminin (c and d), basement membrane chondroitin sulfate proteoglycan (BM-CSPG, e and f), and periecan (g and h) in aortic tissue taken from above the coarctation site of 14-day coarctation hypertensive (a, c, e, and g) and sham (b, d, f, and h) rats. Vascular lumen (L) is to the left of the aortic wall in all micrographs. Note intense staining pattern for BM-CSPG in the subendothelial space (arrows) and basement membrane material surrounding the smooth muscle cells (arrowheads) in control aortas (f) and the reduction in staining in the subendothelial and medial basement membranes of aortas from hypertensive animals (e). Care was taken during all stages of micrograph preparation to keep exposure times constant so that true comparison of staining intensities could be made between experimental and control tissues. Thus, in d laminin is present but there is comparatively much less than in c. Micrographs are representative of comparisons between four hypertensive and four sham rats. Bar=20 ym.
creases in the mRNA levels for periecan and type IV collagen in the AOR t , as well as these BM components and laminin in the AOR 1. These findings suggest that posttranscriptional regulatory mechanisms differentially control the deposition of select BM components in different areas of the aorta of the coarctation hypertensive rat.
The finding that the expression of BM componentspecific mRNAs was greater in the aortas from sham tissues than the coarctation hypertensive tissues at day 20 is paradoxical. It is possible that the sham clip may produce some structural changes within the aorta as the animals grow and the clip becomes progressively constrictive. It is also possible that the marked remodeling of the aorta of the coarctation hypertensive rats has actually reduced the pathological stimuli (such as increased stretch) that originally induced the alterations in mRNA in this group.
Alterations in Basement Membrane Components May Mediate Pathophysiological Alterations in Hypertensive Blood Vessels
Structural alterations in resistance vessels are thought to be the primary mechanisms through which systemic hypertension is mediated. Although this study focused on changes occurring in the aorta, a conducting vessel, it is anticipated that, because resistance vessels have a greater capacity for ECM synthesis owing to their greater relative amount of smooth muscle cell mass to total weight, the response of resistance vessels would also be similar to (or greater than) that observed in the aorta in the present study.
Fibronectin and laminin are important cell attachment molecules. Increased peripheral vascular resistance observed in hypertension may be partly due to increased adhesion of cells to the underlying ECM via these cell attachment proteins, which would elevate the series component of vascular resistance. 52 Enhanced adhesion of vascular smooth muscle to the interstitial matrix may also contribute to the observed increases in vascular reactivity of blood vessels from hypertensive animals 38 -33 -54 through an increase in the attachment of contractile microfilaments within the cell to the surrounding ECM via specifie cell surface receptors.
The BM-CSPG, a component of BMs from many tissues, 29 was decreased in the hypertensive AOR t compared with shams. Little is known about the function of this newly described proteoglycan, but studies performed by Couchman et al 27 indicate that this molecule is present in structurally mature and stable BMs and absent from those of undifferentiated and immature cells. The marked reduction of this component in endothelial and smooth muscle cell BMs of hypertensive aortas, therefore, suggests that aortic BMs undergo a fundamental structural reorganization in response to the hypertensive state, a finding consistent with the observed changes in fibronectin and laminin.
Changes in Myocardial Basement Membranes, Immunohistochemistry and Northern Analysis
Other investigators have reported increases in fibronectin mRNA and increased deposition of fibronectin in the myocardium in response to cardiac injury 55 -56 as well as cardiac hypertrophy 26 associated with systemic hypertension including the coarctation model. 25 - 57 In contrast, in the present study we observed no immunohistochemical alterations in myocardial fibronectin or any other BM component examined in either the RV or LV of coarctation hypertensive rats, despite significant LV hypertrophy. Alterations in mRNA specific for BM components in the hypertrophied LV were also minimal until 20 days after coarctation.
The finding that steady-state levels of fibronectinspecific mRNA were not changed in the hypertrophied LV in the present study supports the finding that, in our model of coarctation hypertension, minimal changes in fibronectin synthesis were observed in this tissue, despite overt hypertrophy. Differences between the present study and those of Contard et al, 25 Mayuma and Brecher, 26 and Villareal and Dillman 37 may reflect differences in cardiac responses to different forms of hypertension, varying degrees of severity of the coarctation, different placement of the coarctation on the vascular tree, differences in the times at which cardiac tissue was examined, or differences in the use of tissues Our results suggest that pressure-overloaded cardiac and aortic tissues may respond and adapt differently to pressure-overload hypertension with regard to the synthesis of BM components. It is also possible that increases in BM component deposition in the hearts of coarctation hypertensive rats do not occur until a time point later than 2 weeks, as suggested by our Northern analysis data.
Northern analyses of changes in mRNA in ventricular tissues are somewhat limited because the ventricles are composed of several distinct tissue types, including endocardium, epicardium, nervous tissue, and the coronary vasculature, all of which contain BMs. Alterations in BM component mRNA observed in the RV and LV in the present study cannot preclude a contribution from these other cell types, particularly when the coronary vasculature is experiencing increased pressure. However, because the overwhelming majority of the mass of ventricular tissue is myocardium, it is expected that the majority of the mRNA would be derived from the myocytes. This study demonstrates that hypertension produced by coarctation of the abdominal aorta leads to marked increases in the synthetic capacity and deposition of specific BM components; conducting vessels are particularly affected. These increases are observed in normotensive and hypertensive portions of the aorta, suggesting that both physical and chemical mediators are involved. A more thorough investigation of other vascular beds, particularly resistance vessels in pressure- 
